CDH17 and cancer: The first one is the dysfunction of cadherin junctions that hold the primary mass together, which has been demonstrated to be a major contributor to cancer progression.[57] Cadherins form adherent junctions between adjacent cells and interact with proteins that link the receptor to fundamental intracellular processes, including arrangement of the cytoskeleton, cell signaling and vesicles traffic.